Browse By Publication: Expert Opinion on Pharmacotherapy

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: No Grouping | Volume | Authors/Creators
Number of items: 62.

Doggrell, Sheila (2006) After the failure of citalopram for depression, what next? Expert Opinion on Pharmacotherapy, 7(11), pp. 1515-1518.
Number of citations in Scopus 3
Number of citations in Web of Science® 3

Doggrell, Sheila (2009) Anti-cancer activity of zoledronic acid in breast cancer. Expert Opinion on Pharmacotherapy, 10(14), pp. 2387-2390.

Doggrell, Sheila (2005) Aspirin and esomeprazole are superior to clopidogrel in preventing recurrent ulcer bleeding. Expert Opinion on Pharmacotherapy, 6(7), pp. 1253-1256.
Number of citations in Scopus 6
Number of citations in Web of Science® 3

Doggrell, Sheila (2005) CHARMed - the effects of candesartan in heart failure. Expert Opinion on Pharmacotherapy, 6(3), pp. 513-516.
Number of citations in Scopus 2

Doggrell, Sheila (2005) CLARITY about the use of clopidogrel in patients with acute coronary syndromes and myocardial infarction. Expert Opinion on Pharmacotherapy, 6(10), pp. 1761-1764.
Number of citations in Scopus 2
Number of citations in Web of Science® 2

Doggrell, Sheila (2008) Celecoxib to prevent restenosis - results from the COREA-TAXUS trial. Expert Opinion on Pharmacotherapy, 9(2), pp. 339-341.
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Doggrell, Sheila (2008) Clinical trials with thiazolidinediones in subjects with Type 2 diabetes - is pioglitazone any different from rosiglitazone? Expert Opinion on Pharmacotherapy, 9(3), pp. 405-420.
Number of citations in Scopus 17
Number of citations in Web of Science® 18

Doggrell, Sheila (2007) Clopidogrel use with stenting. Expert Opinion on Pharmacotherapy, 8(9), pp. 1399-1402.
Number of citations in Scopus 1
Number of citations in Web of Science® 2

Doggrell, Sheila (2005) Comparison of clinical trials with sildenafil, vardenafil and tadalafil in erectile dysfunction. Expert Opinion on Pharmacotherapy, 6(1), pp. 75-84.
Number of citations in Scopus 34
Number of citations in Web of Science® 26

Doggrell, Sheila (2007) Does rosiglitazone increase cardiovascular outcomes? Expert Opinion on Pharmacotherapy, 8(15), pp. 2665-2669.
Number of citations in Scopus 2
Number of citations in Web of Science® 3

Doggrell, Sheila (2005) Fluoxetine - do the benefits outweigh the risks in adolescent major depression? Expert Opinion on Pharmacotherapy, 6(1), pp. 147-150.
Number of citations in Scopus 6
Number of citations in Web of Science® 4

Doggrell, Sheila (2005) Has the controversy over the use of calcium channel blockers in coronary artery disease been resolved? Expert Opinion on Pharmacotherapy, 6(5), pp. 831-834.
Number of citations in Scopus 6
Number of citations in Web of Science® 2

Doggrell, Sheila (2006) Inhibition of RANKL: a new approach to the treatment of osteoporosis. Expert Opinion on Pharmacotherapy, 7(8), pp. 1097-1100.
Number of citations in Scopus 2
Number of citations in Web of Science® 1

Doggrell, Sheila (2006) Is NXY-059 an advancement in the treatment of acute ischaemic stroke? Expert Opinion on Pharmacotherapy, 7(7), pp. 965-968.

Doggrell, Sheila (2006) Is amlodipine the best initial monotherapy for hypertension? Expert Opinion on Pharmacotherapy, 7(6), pp. 829-832.
Number of citations in Scopus 3
Number of citations in Web of Science® 3

Doggrell, Sheila (2006) Is exenatide advancing the treatment of Type 2 diabetes? Expert Opinion on Pharmacotherapy, 7(1), pp. 109-112.
Number of citations in Scopus 3
Number of citations in Web of Science® 3

Doggrell, Sheila (2007) Is fingolimod an advancement in the treatment of multiple sclerosis? Expert Opinion on Pharmacotherapy, 8(3), pp. 383-386.
Number of citations in Scopus 3
Number of citations in Web of Science® 2

Doggrell, Sheila (2009) Is liraglutide or exenatide better in type 2 diabetes? Expert Opinion on Pharmacotherapy, 10(16), pp. 2769-2772.
Number of full-text downloads 738
Number of citations in Scopus 3

Doggrell, Sheila (2008) Is long-term adjuvant treatment of breast cancer with anastrozole indicated? Expert Opinion on Pharmacotherapy, 9(9), pp. 1619-1622.
Number of citations in Scopus 3
Number of citations in Web of Science® 1

Doggrell, Sheila (2008) Is rimonabant efficacious and safe in the treatment of obesity? Expert Opinion on Pharmacotherapy, 9(15), pp. 2727-2731.
Number of citations in Scopus 19
Number of citations in Web of Science® 16

Doggrell, Sheila (2008) Is sapropterin treatment suitable for all subjects with phenylketonuria? Expert Opinion on Pharmacotherapy, 9(1), pp. 145-147.
Number of citations in Scopus 5
Number of citations in Web of Science® 2

Doggrell, Sheila (2005) Is the cannabinoid CB1 receptor antagonist rimonabant advancing the treatment of obesity? Expert Opinion on Pharmacotherapy, 6(12), pp. 2141-2144.

Doggrell, Sheila (2008) Is tocilizumab an option for the treatment of arthritis? Expert Opinion on Pharmacotherapy, 9(11), pp. 2009-2013.

Doggrell, Sheila (2005) More support for high-dose atorvastatin in coronary artery disease. Expert Opinion on Pharmacotherapy, 6(13), pp. 2365-2368.

Doggrell, Sheila (2006) Muraglitazar: beneficial or detrimental in the treatment of Type 2 diabetes? Expert Opinion on Pharmacotherapy, 7(9), pp. 1229-1233.
Number of citations in Scopus 5
Number of citations in Web of Science® 6

Doggrell, Sheila (2006) Natalizumab in multiple sclerosis: proceed with caution? Expert Opinion on Pharmacotherapy, 7(12), pp. 1675-1678.
Number of citations in Scopus 2
Number of citations in Web of Science® 2

Doggrell, Sheila (2010) New drugs for the treatment of coronary artery syndromes. Expert Opinion on Pharmacotherapy, 11(2), pp. 325-329.
Number of full-text downloads 228

Doggrell, Sheila (2009) New findings with old drugs for osteoporosis. Expert Opinion on Pharmacotherapy, 10(3), pp. 513-516.
Number of full-text downloads 182
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Doggrell, Sheila (2008) New indications for topiramate: alcohol dependency and binge-eating disorder. Expert Opinion on Pharmacotherapy, 9(5), pp. 869-873.
Number of citations in Scopus 4
Number of citations in Web of Science® 1

Doggrell, Sheila (2006) Partial agonism at nicotinic receptors with varenicline - a new approach to smoking cessation. Expert Opinion on Pharmacotherapy, 7(18), pp. 2599-2603.
Number of citations in Scopus 1

Doggrell, Sheila (2005) Pegaptanib: the first antiangiogenic agent approved for neovascular macular degeneration. Expert Opinion on Pharmacotherapy, 6(8), pp. 1421-1423.
Number of citations in Scopus 40
Number of citations in Web of Science® 35

Doggrell, Sheila (2006) Phosphodiesterase 4 inhibition with roflumilast: a new approach to pulmonary disease. Expert Opinion on Pharmacotherapy, 7(4), pp. 485-488.
Number of citations in Scopus 2
Number of citations in Web of Science® 2

Doggrell, Sheila (2005) Pregabalin or morphine and gabapentin for neuropathic pain. Expert Opinion on Pharmacotherapy, 6(14), pp. 2535-2539.
Number of citations in Scopus 8
Number of citations in Web of Science® 6

Doggrell, Sheila (2006) Recent evidence of sustained benefit with exenatide in Type 2 diabetes. Expert Opinion on Pharmacotherapy, 7(14), pp. 2003-2006.
Number of citations in Scopus 7
Number of citations in Web of Science® 6

Doggrell, Sheila (2005) Recent findings with docetaxel in postoperative treatment for breast cancer. Expert Opinion on Pharmacotherapy, 6(16), pp. 2903-2906.

Doggrell, Sheila (2005) Recent important trials of pharmacotherapy in Parkinson's disease. Expert Opinion on Pharmacotherapy, 6(6), pp. 1025-1028.

Doggrell, Sheila (2005) Relating statin therapy to C-reactive protein levels. Expert Opinion on Pharmacotherapy, 6(9), pp. 1597-1600.
Number of citations in Scopus 7
Number of citations in Web of Science® 7

Doggrell, Sheila (2007) Rosiglitazone: rosy news for a thiazolidinedione. Expert Opinion on Pharmacotherapy, 8(2), pp. 265-268.
Number of citations in Scopus 1

Doggrell, Sheila (2006) Sibutramine for obesity in adolescents. Expert Opinion on Pharmacotherapy, 7(17), pp. 2435-2438.
Number of citations in Scopus 3
Number of citations in Web of Science® 2

Doggrell, Sheila (2006) 'Simply stunning' - trastuzumab in HER2-positive breast cancer. Expert Opinion on Pharmacotherapy, 7(5), pp. 631-634.
Number of citations in Scopus 3
Number of citations in Web of Science® 3

Doggrell, Sheila (2006) Sirolimus- or paclitaxel-eluting stents for coronary artery revascularisation. Expert Opinion on Pharmacotherapy, 7(2), pp. 225-228.
Number of citations in Scopus 2

Doggrell, Sheila (2011) Sitagliptin or exenatide once weekly for type 2 diabetes: Comparison of the clinical trials. Expert Opinion on Pharmacotherapy, 12(13), pp. 2055-2067.
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Doggrell, Sheila (2011) Treatment for relapsed Hodgkin lymphoma: Refinement of chemotherapy or targeted treatment? Expert Opinion on Pharmacotherapy, 12(6), pp. 991-994.

Doggrell, Sheila (2005) Which drug combination for hormone-refractory prostate cancer? Expert Opinion on Pharmacotherapy, 6(4), pp. 667-670.
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Doggrell, Sheila (2006) Which treatment for alcohol dependence: naltrexone, acamprosate and/or behavioural intervention? Expert Opinion on Pharmacotherapy, 7(15), pp. 2169-2173.
Number of citations in Scopus 3
Number of citations in Web of Science® 3

Doggrell, Sheila (2005) Ximelagatran - recent comparisons with warfarin. Expert Opinion on Pharmacotherapy, 6(11), pp. 1943-1946.
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Doggrell, Sheila (2012) The ezetimibe controversy? Can this be resolved by comparing the clinical trials with simvastatin and ezetimibe alone and together? Expert Opinion on Pharmacotherapy, 13(10), pp. 1469-1480.
Number of full-text downloads 140
Number of citations in Scopus 10
Number of citations in Web of Science® 12

Doggrell, Sheila (2005) The safety of lumiracoxib when used in the treatment of arthritis. Expert Opinion on Pharmacotherapy, 6(2), pp. 347-350.
Number of citations in Scopus 11
Number of citations in Web of Science® 7

Doggrell, Sheila & Christensen, Anne-Marie (2011) Are there better Bcr-Abl kinase inhibitors for chronic myeloid leukaemia than imatinib? Expert Opinion on Pharmacotherapy, 12(1), pp. 157-163.
Number of citations in Scopus 4
Number of citations in Web of Science® 3

Doggrell, Sheila & Dimmitt, Simon B. (2016) Sitagliptin and other ‘gliptins’ - why prescribe them? Expert Opinion on Pharmacotherapy, 17(6), pp. 757-760.
Number of citations in Scopus 1

Doggrell, Sheila & Hancox, Jules (2012) PALLAS : limiting indications for dronedarone treatment of atrial fibrillation. Expert Opinion on Pharmacotherapy, 13(6), pp. 867-871.
Number of full-text downloads 34
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Doggrell, Sheila & McIntyre, Kerry (2014) Canagliflozin : something new for type 2 diabetes, but is it safe and efficacious? Expert Opinion on Pharmacotherapy, 15(3), pp. 437-441.
Number of full-text downloads 380
Number of citations in Scopus 5
Number of citations in Web of Science® 4

Doggrell, Sheila A. & Tuli, Rinku (2014) Dapagliflozin – do we need it registered for type 2 diabetes? Expert Opinion on Pharmacotherapy, 15(11), pp. 1631-1635.
Number of full-text downloads 46
Number of citations in Scopus 1
Number of citations in Web of Science® 2

Doggrell, Sheila Anne (2013) Comment on: Clinical benefits of ezetimibe : absence of proof is just that. Expert Opinion on Pharmacotherapy, 14(18), pp. 2611-2613.
Number of full-text downloads 30
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Doggrell, Sheila Anne (2010) Oral fingolimod for relapsing-remitting multiple sclerosis. Expert Opinion on Pharmacotherapy, 11(10), pp. 1777-1781.
Number of full-text downloads 21
Number of citations in Scopus 7
Number of citations in Web of Science® 4

Doggrell, Sheila Anne & Chan, Vincent (2012) Bariatric surgery or medicine for type 2 diabetes? Expert Opinion on Pharmacotherapy, 13(15), pp. 2249-2253.
Number of citations in Scopus 3
Number of citations in Web of Science® 3

Doggrell, Sheila Anne & Christensen, Anne-Marie (2010) Does the p38 MAP kinase inhibitor pamapimod have potential for the treatment of rheumatoid arthritis? Expert Opinion on Pharmacotherapy, 11(14), pp. 2437-2442.
Number of full-text downloads 140
Number of citations in Scopus 2
Number of citations in Web of Science® 1

Johnson, Matthew P., Fernandez, Francesca, Colson, Natalie J., & Griffiths, Lyn R. (2007) A pharmacogenomic evaluation of migraine therapy. Expert Opinion on Pharmacotherapy, 8(12), pp. 1821-1835.
Number of citations in Scopus 12
Number of citations in Web of Science® 11

This list was generated on Sun May 28 12:37:59 2017 AEST.